Are KMC Speciality Hospitals (India) Ltd latest results good or bad?

1 hour ago
share
Share Via
KMC Speciality Hospitals (India) Ltd reported strong Q4 FY26 results with a net profit of ₹14.63 crores, up 223.67% year-on-year, and record revenue of ₹82.25 crores, a 34.99% increase. Despite slight quarter-on-quarter growth declines, the overall performance reflects effective cost management and operational efficiency.
KMC Speciality Hospitals (India) Ltd has reported its financial results for the fourth quarter of FY26, showcasing significant operational achievements. The company recorded a net profit of ₹14.63 crores, which reflects a substantial year-on-year growth of 223.67%. Additionally, the revenue for the quarter reached ₹82.25 crores, marking a year-on-year increase of 34.99%. This performance is notable as it represents the highest quarterly revenue in the company's history.
The operating margin for Q4 FY26 reached an all-time high of 31.47%, which is a 620-basis-point improvement from the previous year. This margin expansion indicates effective management of costs and enhanced operational efficiency, contributing to the overall profitability of the company. Furthermore, the return on equity (ROE) stood at 20.10%, demonstrating strong capital efficiency. For the full fiscal year FY26, KMC Speciality achieved consolidated revenue of ₹305.76 crores, up 32.36% year-on-year, and a net profit of ₹46.74 crores, which represents a 122.57% increase compared to the previous fiscal year. The earnings per share also improved significantly, from ₹1.29 in FY25 to ₹2.87 in FY26, reflecting the company's ability to enhance profitability while maintaining healthy revenue growth. Despite the positive results, the company experienced a slight quarter-on-quarter revenue growth of 0.23% in Q4 FY26, which is a reduction from the previous quarter's growth of 9.56%. Similarly, the standalone net profit growth of 6.55% in Q4 FY26 was lower than the 26.66% growth recorded in the prior quarter. Overall, KMC Speciality Hospitals has demonstrated a strong operational performance with record revenue and profit figures, although there has been a minor adjustment in its evaluation. The company’s consistent revenue growth and margin expansion highlight its successful capacity expansion and operational efficiency initiatives, positioning it favorably within the healthcare sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News